Closed-loop insulin delivery systems linking subcutaneous insulin infusion to real-time continuous glucose monitoring need to be evaluated in humans, but progress can be accelerated with the use of in silico testing. We present a simulation environment designed to support the development and testing of closed-loop insulin delivery systems in type 1 diabetes mellitus (T1DM).
Methods:
The principal components of the simulation environment include a mathematical model of glucose regulation representing a virtual population with T1DM, the glucose measurement model, and the insulin delivery model. The simulation environment is highly flexible. The user can specify an experimental protocol, define a population of virtual subjects, choose glucose measurement and insulin delivery models, and specify outcome measures. The environment provides graphical as well as numerical outputs to enable a comprehensive analysis of in silico study results. The simulation environment is validated by comparing its predictions against a clinical study evaluating overnight closed-loop insulin delivery in young people with T1DM using a model predictive controller.
Results:
The simulation model of glucose regulation is described, and population values of 18 synthetic subjects are provided. The validation study demonstrated that the simulation environment was able to reproduce the population results of the clinical study conducted in young people with T1DM.
Conclusions:
Closed-loop trials in humans should be preceded and concurrently guided by highly efficient and resource-saving computer-based simulations. We demonstrate validity of population-based predictions obtained with our simulation environment.
HovorkaRWilinskaMEChassinLJDungerDB.Roadmap to the artificial pancreas. Diabetes Res Clin Pract.2006;74 (Suppl 2): S178–82.
4.
JDRF Artificial Pancreas Project, 2008. http://www.idrf.org. Accessed on May 20, 2009.
5.
BuckinghamBABlockJWilsonDRebrinKSteilG.Novolog pharmacodynamics in toddlers. Diabetes.2005;54 (Suppl 1): A454.
6.
PatekSDBequetteBWBretonMBuckinghamBADassauEDoyleFJIIILumJMagniLZisserH.In silico preclinical trials: methodology and engineering guide to closed-loop control in type 1 diabetes mellitus. J Diabetes Sci Technol.2009;3 (2): 269–82.
7.
HovorkaRAceriniCLAllenJChassinLJLarsenAMDe PalmaAWilinskaMEDungerDB.Overnight sc-sc closed-loop control improves glucose control and reduces risk of hypoglycaemia in children and adolescents with type 1 diabetes. Diabetes.2008;57 (Suppl 1): A22.
8.
HovorkaRAceriniCLAllenJChassinLJLarsenAFMundtDDe PalmaAWilinskaMEDungerDB.Good overnight closed-loop glucose control in children and adolescents with type 1 diabetes following ingestion of large, rapidly and slowly absorbed evening meal. Diabetologia.2008;51: S81–181.
9.
WilinskaMEChassinLJHovorkaR.The role of simulation environment in the development of artificial pancreas for overnight glucose control in children and adolescents with type 1 diabetes. J Diabetes Sci Technol.2008;2 (2): A183.
10.
KovatchevBPBretonMManCDCobelliC.In silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes. J Diabetes Sci Technol.2009;3 (1): 44–55.
11.
WilinskaMEChassinLJHovorkaR.In silico testing—impact on the progress of the Closed Loop Insulin Infusion for Critically Ill Patients project. J Diabetes Sci Technol.2008;2 (3): 417–23.
12.
ChaseJGShawGMLotzTLeCompteAWongJLinJLonerganTWillacyMHannCE.Model-based insulin and nutrition administration for tight glycaemic control in critical care. Curr Drug Deliv.2007;4 (4): 283–96.
13.
Van HerpeTEspinozaMPluymersBGoethalsIWoutersPVan den BergheGDe MoorB.An adaptive input-output modeling approach for predicting the glycemia of critically ill patients. Physiol Meas.2006;27 (11): 1057–69.
14.
LonerganTLe CompteAWillacyMChaseJGShawGMWongXWLotzTLinJHannCE.A simple insulin-nutrition protocol for tight glycemic control in critical illness: development and protocol comparison. Diabetes Technol Ther.2006;8 (2): 191–206.
15.
HovorkaRChassinLJEllmererMPlankJWilinskaME.A simulation model of glucose regulation in the critically ill. Physiol Meas.2008;29 (8): 959–78.
16.
HovorkaRShojaee-MoradieFCarrollPVChassinLJGowrieIJJacksonNCTudorRSUmplebyAMJonesRH.Partitioning glucose distribution/transport, disposal, and endogenous production during IVGTT. Am J Physiol Endocrinol Metab.2002;282 (5): E992–1007.
17.
KovatchevBPCoxDJGonder-FrederickLAClarkeW.Symmetrization of the blood glucose measurement scale and its applications. Diabetes Care.1997;20 (11): 1655–8.
18.
ChassinLJWilinskaMEHovorkaR.Grading system to assess clinical performance of closed-loop glucose control. Diabetes Technol Ther.2005;7 (1): 72–82.
19.
WilinskaMEBudimanESTaubMBElleriDAllenJMAceriniCLDungerDBHovorkaR.Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studies. J Diabetes Sci Technol.2009;3 (5): 1109–20.
20.
Shojaee-MoradieFCarrollPVChassinLJGowrieIJJacksonNCJonesRHTudorRSUmplebyAMHovorkaR.Partitioning glucose transport/distribution and disposal during euglycaemic clamp. Diabetologia.2001;44 (Suppl 1): 792.
21.
WorthingtonDR.Minimal model of food absorption in the gut. Med Inform (Lond).1997;22 (1): 35–45.
22.
HovorkaRKremenJBlahaJMatiasMAnderlovaKBosanskaLRoubicekTWilinskaMEChassinLJSvacinaSHaluzikM.Blood glucose control by a model predictive control algorithm with variable sampling rate versus a routine glucose management protocol in cardiac surgery patients: a randomized controlled trial. J Clin Endocrinol Metab.2007;92 (8): 2960–4.
23.
HovorkaRCanonicoVChassinLJHaueterUMassi-BenedettiMFedericiM OrsiniPieberTRSchallerHCSchauppLVeringTWilinskaME.Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes. Physiol Meas.2004;25 (4): 905–20.
24.
SilinkM.Childhood diabetes: a global perspective. Horm Res.2002;57Suppl 1: 1–5.
25.
BennJJBozzardSJKelleyDMitrakouAAokiTSorensenJGerichJSonksenPH.Persistent abnormalities of the metabolism of an oral glucose load in insulin-treated type 1 diabetics. Metabolism.1989;38 (11): 1047–55.
26.
WilinskaMEBodenlenzMChassinLJSchallerHCSchauppLAPieberTRHovorkaR.Interstitial glucose kinetics in subjects with type 1 diabetes under physiologic conditions. Metabolism.2004;53 (11): 1484–91.
27.
BequetteBW. Editorial: Symposium on algorithms for continuous glucose monitoring and control. Diabetes Technol Ther.2005;7 (1): 1–2.
28.
MazorEAverbuchABar-ShalomYDayanJ.Interacting multiple model methods in target tracking: a survey. IEEE Trans Aerospace Electronic Sys.1998;34 (1): 103–23.
29.
ChassinLJWilinskaMEHovorkaR.Evaluation of glucose controllers in virtual environment: methodology and sample application. Artif Intell Med.2004;32 (3): 171–81.
30.
Dalla ManCRizzaRACobelliC.Meal simulation model of the glucose-insulin system. IEEE Trans Biomed Eng.2007;54 (10): 1740–9.
31.
HovorkaRChassinLJWilinskaMECanonicoVAkwiJAFedericiMOMassi-BenedettiMHutzliIZauggCKaufmannHBothMVeringTSchallerHCSchauppLBodenlenzMPieberTR.Closing the loop: the adicol experience. Diabetes Technol Ther.2004;6 (3): 307–18.
32.
SteilGMReifmanJ.Mathematical modeling research to support the development of automated insulin-delivery systems. J Diabetes Sci Technol.2009;3 (2): 388–95.
33.
EddyDMSchlessingerL.Archimedes: a trial-validated model of diabetes. Diabetes Care.2003;26 (11): 3093–101.
34.
EddyDMSchlessingerL.Validation of the archimedes diabetes model. Diabetes Care.2003;26 (11): 3102–10.
35.
LehmannEDDeutschTRoudsariAVCarsonERSonksenPH.Validation of a metabolic prototype to assist in the treatment of insulin-dependent diabetes mellitus. Med Inform (Lond).1993;18 (2): 83–101.
AndreassenSBennJJHovorkaROlesenKGCarsonER.A probabilistic approach to glucose prediction and insulin dose adjustment: description of metabolic model and pilot evaluation study. Comput Methods Programs Biomed.1994;41 (3–4): 153–65.
